Literature DB >> 12438921

Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies.

Akihiko Nunomura1, Shigeru Chiba, Kenji Kosaka, Atsushi Takeda, Rudy J Castellani, Mark A Smith, George Perry.   

Abstract

An approach was used to identify the oxidized nucleoside, 8-hydroxyguanosine in brains of dementia with Lewy bodies. Neurons with marked immunoreaction of 8-hydroxyguanosine in the cytoplasm were widely distributed in the hippocampal region and temporal neocortex. Relative intensity measurements of neuronal 8-hydroxyguanosine immunoreactivity showed that there was a significant increase in nucleic acid oxidation in dementia with Lewy bodies compared with controls. Treatment with nuclease (DNase or RNase) before the immunostaining demonstrated that RNA was a major site of nucleic acid oxidation. Together with the previously reported RNA oxidation in vulnerable neurons in Alzheimer and Parkinson diseases, neuronal RNA oxidation in dementia with Lewy bodies might represent one of the fundamental abnormalities in age-associated neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438921     DOI: 10.1097/00001756-200211150-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  29 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondria.

Authors:  Mikiei Tanaka; Pawel Jaruga; Pascal A Küpfer; Christian J Leumann; Miral Dizdaroglu; William E Sonntag; P Boon Chock
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

3.  The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Authors:  Akihiko Nunomura; Toshio Tamaoki; Nobutaka Motohashi; Masao Nakamura; Daniel W McKeel; Massimo Tabaton; Hyoung-Gon Lee; Mark A Smith; George Perry; Xiongwei Zhu
Journal:  J Neuropathol Exp Neurol       Date:  2012-03       Impact factor: 3.685

4.  Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain.

Authors:  Changxing Shao; Shuling Xiong; Guo-Min Li; Liya Gu; Guogen Mao; William R Markesbery; Mark A Lovell
Journal:  Free Radic Biol Med       Date:  2008-06-11       Impact factor: 7.376

Review 5.  Quality control of chemically damaged RNA.

Authors:  Carrie L Simms; Hani S Zaher
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

6.  Oxidized messenger RNA induces translation errors.

Authors:  Mikiei Tanaka; P Boon Chock; Earl R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

7.  Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts.

Authors:  Gaetan Deslee; Tracy L Adair-Kirk; Tomoko Betsuyaku; Jason C Woods; Carla H Moore; David S Gierada; Susan H Conradi; Jeffrey J Atkinson; Holly M Toennies; John T Battaile; Dale K Kobayashi; G Alexander Patterson; Michael J Holtzman; Richard A Pierce
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

Review 8.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

9.  RNA under attack: cellular handling of RNA damage.

Authors:  Elisabeth J Wurtmann; Sandra L Wolin
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jan-Feb       Impact factor: 8.250

10.  Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Authors:  Rudy J Castellani; Akihiko Nunomura; Raj K Rolston; Paula I Moreira; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.